The latest thoracic oncology news
DNA methylation as a biomarker for early diagnosis of lung cancer
Early diagnosis of lung cancer is a critical priority in clinical practice. It may help…
Browsing: Lung Cancer
New genetic mutation linked to drug resistance in non-small cell lung cancer patient
A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET…
New screening device shows promise for early lung cancer detection
Scientists have created a new low-cost, fast-response sensor to detect lung cancer biomarkers, paving the…
Medical experts launch Australia’s first lung cancer molecular testing best practice recommendations ahead of National Lung Cancer Screening Program
The Royal College of Pathologists of Australasia (RCPA), in collaboration with the Thoracic Oncology Group…
Study finds key biomarker to predict KRASG12C inhibitor effectiveness in lung cancer
A new study from Moffitt Cancer Centre could help doctors predict how well patients with…
European Commission approves lazertinib in combination with amivantamab for the first-line treatment of patients with EGFR-mutated advanced NSCLC
Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the European Commission (EC)…
New dual stem cell therapy developed to treat brain metastasis in patients with non-small cell lung cancer
New research highlights the promise of a novel stem cell treatment strategy for leptomeningeal brain…
Lung cancer test predicts survival in early stages better than current methods
Researchers at the Francis Crick Institute, the UCL Cancer Institute, and UCLH have shown that a…
Tumour DNA in the blood can predict lung cancer outcome
Circulating tumour DNA (ctDNA) is fragments of DNA released into the blood by tumours. It’s…
Collaborators highlights global trends in risk factors linked to lung cancer deaths
Even though lung and related cancer deaths decreased in the world’s 10 most populous countries…